{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:43:25Z","timestamp":1793972605745,"version":"4.8.0"},"reference-count":54,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Science Foundation","award":["18-75-10114-P"],"award-info":[{"award-number":["18-75-10114-P"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Vancomycin and daptomycin are first-line drugs for the treatment of complicated methicillin-resistant Staphylococcus aureus (MRSA) infections, including bacteremia. However, their effectiveness is limited not only by their resistance to each antibiotic but also by their associated resistance to both drugs. It is unknown whether novel lipoglycopeptides can overcome this associated resistance. Resistant derivatives from five S. aureus strains were obtained during adaptive laboratory evolution with vancomycin and daptomycin. Both parental and derivative strains were subjected to susceptibility testing, population analysis profiles, measurements of growth rate and autolytic activity, and whole-genome sequencing. Regardless of whether vancomycin or daptomycin was selected, most of the derivatives were characterized by a reduced susceptibility to daptomycin, vancomycin, telavancin, dalbavancin, and oritavancin. Resistance to induced autolysis was observed in all derivatives. Daptomycin resistance was associated with a significant reduction in growth rate. Resistance to vancomycin was mainly associated with mutations in the genes responsible for cell wall biosynthesis, and resistance to daptomycin was associated with mutations in the genes responsible for phospholipid biosynthesis and glycerol metabolism. However, mutations in walK and mprF were detected in derivatives selected for both antibiotics.<\/jats:p>","DOI":"10.3390\/antibiotics12050928","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:09:44Z","timestamp":1684397384000},"page":"928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3480-8089","authenticated-orcid":false,"given":"Vladimir","family":"Gostev","sequence":"first","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"},{"name":"Department of Medical Microbiology, North-Western State Medical University named after I.I. Mechnikov, 195067 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kalinogorskaya","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7825-273X","authenticated-orcid":false,"given":"Julia","family":"Sopova","sequence":"additional","affiliation":[{"name":"Center of Transgenesis and Genome Editing, Saint Petersburg State University, 199034 Saint Petersburg, Russia"},{"name":"Saint Petersburg Branch of Vavilov Institute of General Genetics, Russian Academy of Sciences, 198504 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelia","family":"Sulian","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Chulkova","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Velizhanina","sequence":"additional","affiliation":[{"name":"Center of Transgenesis and Genome Editing, Saint Petersburg State University, 199034 Saint Petersburg, Russia"},{"name":"Laboratory of Signal Regulation, All-Russia Research Institute for Agricultural Microbiology, Pushkin, 196608 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Tsvetkova","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Ageevets","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3963-0144","authenticated-orcid":false,"given":"Vladimir","family":"Ageevets","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-7875","authenticated-orcid":false,"given":"Sergey","family":"Sidorenko","sequence":"additional","affiliation":[{"name":"Pediatric Research and Clinical Center for Infectious Diseases, Department of Medical Microbiology and Molecular Epidemiology, 197022 Saint Petersburg, Russia"},{"name":"Department of Medical Microbiology, North-Western State Medical University named after I.I. Mechnikov, 195067 Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e01216-19","DOI":"10.1128\/AAC.01216-19","article-title":"Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents","volume":"63","author":"Watkins","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkw060","article-title":"Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin","volume":"71","author":"Lin","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.4081\/idr.2017.7008","article-title":"Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin","volume":"9","author":"Koton","year":"2017","journal-title":"Infect. Dis. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkr066","article-title":"Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): Implications for therapy after vancomycin treatment failure","volume":"66","author":"Kelley","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10096-008-0692-2","article-title":"Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)","volume":"28","author":"Cunha","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis. Off Publ. Eur. Soc. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1093\/jac\/dkv225","article-title":"Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia","volume":"70","author":"Chen","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.coph.2010.06.006","article-title":"Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus","volume":"10","author":"Nannini","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"970146","DOI":"10.3389\/fmicb.2022.970146","article-title":"Proteome profiling of evolved methicillin-resistant Staphylococcus aureus strains with distinct daptomycin tolerance and resistance phenotypes","volume":"13","author":"Sulaiman","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/AAC.00425-13","article-title":"Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3","volume":"57","author":"Matsuo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.00420-16","article-title":"Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S","volume":"60","author":"Katayama","year":"2016","journal-title":"aureus. Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"36116","DOI":"10.1074\/jbc.M113.516302","article-title":"Catabolite control protein E (CcpE) is a LysR-type transcriptional regulator of tricarboxylic acid cycle activity in Staphylococcus aureus","volume":"288","author":"Hartmann","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e11764","DOI":"10.7717\/peerj.11764","article-title":"Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)","volume":"9","author":"Su","year":"2021","journal-title":"PeerJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1128\/JCM.01320-14","article-title":"Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates","volume":"52","author":"Holmes","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16107","DOI":"10.1038\/s41598-020-73108-x","article-title":"Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"10","author":"Thitiananpakorn","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.04990-14","article-title":"Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics","volume":"59","author":"Berti","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in Glycopeptide Antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/antibiotics3040572","article-title":"Old and New Glycopeptide Antibiotics: Action and Resistance","volume":"3","author":"Binda","year":"2014","journal-title":"Antibiotics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/cid\/civ534","article-title":"Telavancin:Mechanisms of action, in vitro activity, and mechanisms of resistance","volume":"61","author":"Karlowsky","year":"2015","journal-title":"Clin. Infect. Dis. Off Publ. Infect. Dis. Soc. Am."},{"key":"ref_20","first-page":"429.e1","article-title":"Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen","volume":"24","author":"Werth","year":"2018","journal-title":"Clin. Microbiol. Infect. Off Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jcpt.12580","article-title":"Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin","volume":"43","author":"Steele","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41426-018-0205-z","article-title":"Emergence of a dalbavancin induced glycopeptide\/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis","volume":"7","author":"Kussmann","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.3389\/fmicb.2017.02199","article-title":"Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure","volume":"8","author":"Li","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_24","first-page":"2163","article-title":"Novel Mutation Sites in the Development of Vancomycin- Intermediate Resistance in Staphylococcus aureus","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","article-title":"An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus","volume":"54","author":"Cui","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.04290-14","article-title":"Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2","volume":"59","author":"Hu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fmicb.2016.01601","article-title":"Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus","volume":"7","author":"Hu","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00432-10","article-title":"VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e01659-18","DOI":"10.1128\/mBio.01659-18","article-title":"Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance","volume":"9","author":"Ernst","year":"2018","journal-title":"mBio"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0168722","DOI":"10.1128\/spectrum.01687-22","article-title":"Mutation in the Two-Component System Regulator YycH Leads to Daptomycin Tolerance in Methicillin-Resistant Staphylococcus aureus upon Evolution with a Population Bottleneck","volume":"10","author":"Sulaiman","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30823","DOI":"10.1038\/srep30823","article-title":"Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system","volume":"6","author":"Cameron","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1128\/AAC.47.6.2036-2039.2003","article-title":"Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance","volume":"47","author":"Challapalli","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Howden, B.P., McEvoy, C.R., Allen, D.L., Chua, K., Gao, W., Harrison, P.F., Bell, J., Coombs, G., Bennett-Wood, V., and Porter, J.L. (2011). Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002359"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/jac\/dkz562","article-title":"Occurrence of cross-resistance and beta-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels","volume":"75","author":"Hines","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/mdr.2012.0195","article-title":"Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant","volume":"19","author":"Song","year":"2013","journal-title":"Microb. Drug Resist."},{"key":"ref_37","first-page":"910.e1","article-title":"Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus","volume":"27","author":"Werth","year":"2021","journal-title":"Clin. Microbiol. Infect. Off Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.00417-08","article-title":"Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype","volume":"52","author":"Camargo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1134\/S1022795420030060","article-title":"Selection of Resistance to Daptomycin in Methicillin-Resistant Staphylococcus aureus: Role of Homo- and Hetero-Mutations","volume":"56","author":"Gostev","year":"2020","journal-title":"Russ. J. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e2118262119","DOI":"10.1073\/pnas.2118262119","article-title":"Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories","volume":"119","author":"Fait","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/AAC.03022-15","article-title":"Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon","volume":"60","author":"Mechler","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/dkab356","article-title":"Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated beta-lactam sensitization in clinical MRSA strains","volume":"77","author":"Taglialegna","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"eaba0862","DOI":"10.1126\/science.aba0862","article-title":"Clinically relevant mutations in core metabolic genes confer antibiotic resistance","volume":"371","author":"Lopatkin","year":"2021","journal-title":"Science"},{"key":"ref_44","first-page":"468","article-title":"Detecting rare structural variation in evolving microbial populations from new sequence junctions using breseq","volume":"5","author":"Deatherage","year":"2014","journal-title":"Front. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/10766290152652846","article-title":"A microdilution plating method for population analysis of antibiotic-resistant staphylococci","volume":"7","author":"Pfeltz","year":"2001","journal-title":"Microb. Drug Resist."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sprouffske, K., and Wagner, A. (2016). Growthcurver: An R package for obtaining interpretable metrics from microbial growth curves. BMC Bioinform., 17.","DOI":"10.1186\/s12859-016-1016-7"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00067-18","DOI":"10.1128\/mBio.00067-18","article-title":"Efficient and Scalable Precision Genome Editing in Staphylococcus aureus through Conditional Recombineering and CRISPR\/Cas9-Mediated Counterselection","volume":"9","author":"Penewit","year":"2018","journal-title":"mBio"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J. Comput. Biol. J. Comput. Mol. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/bioinformatics\/btx373","article-title":"FQC Dashboard: Integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool","volume":"33","author":"Brown","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/bioinformatics\/btt086","article-title":"QUAST: Quality assessment tool for genome assemblies","volume":"29","author":"Gurevich","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Barrick, J.E., Colburn, G., Deatherage, D.E., Traverse, C.C., Strand, M.D., Borges, J.J., Knoester, D.B., Reba, A., and Meyer, A.G. (2014). Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq. BMC Genomics, 15.","DOI":"10.1186\/1471-2164-15-1039"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/5\/928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:37:44Z","timestamp":1760125064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/5\/928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["antibiotics12050928"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12050928","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}